↓ Skip to main content

Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

Overview of attention for article published in BMC Cancer, March 2022
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma
Published in
BMC Cancer, March 2022
DOI 10.1186/s12885-022-09270-4
Pubmed ID
Authors

R. Mercieca-Bebber, E. H. Barnes, K. Wilson, Z. Samoon, E. Walpole, T. Mai, S. Ackland, M. Burge, G. Dickie, D. Watson, J. Leung, T. Wang, R. Bohmer, D. Cameron, J. Simes, V. Gebski, M. Smithers, J. Thomas, J. Zalcberg, A. P. Barbour

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 14%
Student > Bachelor 3 14%
Student > Master 3 14%
Unknown 12 57%
Readers by discipline Count As %
Unspecified 3 14%
Nursing and Health Professions 2 10%
Biochemistry, Genetics and Molecular Biology 1 5%
Computer Science 1 5%
Psychology 1 5%
Other 2 10%
Unknown 11 52%